ESO/AccuMed Partner to Create Premium Billing Solutions for EMS; ESO Solutions Acquires The AccuMed Group’s Electronic Patient Care Reporting Division
Austin, Texas (PRWEB) October 10, 2013 -- The acquisition agreement calls for ESO Solutions to become the exclusive ePCR provider to agencies who currently use AccuMed’s ePCR software. Via the acquisition, AccuMed’s customers will join over 700 agencies nation-wide that use ESO’s award winning ePCR solution and integrated software suite, which seamlessly connects the pre-hospital industry with the healthcare ecosystem, facilitating the access and sharing of information. As a result, patient information is available when and where it is needed to save lives and care becomes a collaborative effort between all providers.
“We’re looking forward to transitioning customers to ESO’s cutting edge ePCR software as well as integrating AccuMed’s progressive revenue-enhancing tools with ESO’s ePCR,” said Ned Suddendorf, Chief Operations Officer of The AccuMed Group. “This combined solution will deliver results and functionality not yet seen by the EMS/Fire community.”
The ESO/AccuMed billing partnership will create a revolutionary, state-of-the art data and billing solution, exclusively available to AccuMed/ESO clients. This newly formed process accelerates compliant revenue generation by categorizing receivables from the onset, by payor source, enabling each payer group to receive specialized attention and action.
AccuMed and ESO Solutions have made substantive investments to deliver a true end to end, full service solution. This solution includes built-in validation tools to help ensure that end users capture required medical information – such as call location, patient identification, assessment, treatment, destination, and billing information –on the call. Once incidents are “approved” for billing through ESO’s software, incidents migrate to AccuMed’s proprietary pre-processing systems within hours. An automated process verifies scope and accuracy of insurance coverage and “fast tracks” the incident to a certified coder for processing. Any incidents requiring additional information are routed to the Insurance Verification Department where missing information is developed and coded to create a compliant claim.
“The acquisition of the ePCR Division of AccuMed is exciting for ESO. Not only do we get the chance to work with AccuMed's fantastic customer base, but we have the opportunity to partner with a progressive company that has demonstrated a commitment to delivering solutions that position their clients for success today and for the future. AccuMed has an impressive track record of 24-plus years of excellent customer service we are proud to partner with. In fact, AccuMed has been chosen as a Platinum Billing Partner; only one-of-three nationwide. Together, ESO and AccuMed are a tough combination to beat," remarked Chris Dillie, CEO of ESO Solutions.
About ESO Solutions
ESO Solutions, Inc., founded in 2004 and headquartered in Austin, Texas, employs industry leaders in EMS, software design and information technology to create software solutions for the healthcare industry. ESO Solutions’ products help healthcare providers and administrators save time, improve documentation quality and operational efficiencies, and enhance the continuum of patient care. For more information about ESO Solutions, visit http://www.esosolutions.com.
About The AccuMed Group
The AccuMed Group is a Michigan based, nationally represented EMS billing, consultation, collection and reporting solutions leader bringing 24 years of experience, highly effective billing processes and customer service excellence to the EMS/Fire industry. The AccuMed Group’s progressive business model helps life safety systems achieve full compliance with regulatory entities, optimize revenue and reduce administrative costs in support of business side operations. For more information about The AccuMed Group, visit http://www.theaccumedgroup.com.
Caitlin Swahn, ESO Solutions, http://www.esosolutions.com, +1 5123514814, [email protected]
Share this article